These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 24021531)

  • 1. Intravascular large B cell lymphoma: widespread but not everywhere.
    Ponzoni M; Ferreri AJ
    Acta Haematol; 2014; 131(1):16-7. PubMed ID: 24021531
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Fabbri A; Gozzetti A; Rigacci L
    Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
    Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of concomitant diffuse large B-cell lymphoma and myelodysplastic syndrome.
    Dozzo M; Zaja F; Volpetti S; Chiozzotto M; Puglisi S; Mazzucco M; Perali G; Fanin R
    Am J Hematol; 2014 Oct; 89(10):1011-3. PubMed ID: 24912474
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis of a primary cardiac B-cell lymphoma.
    Menke J; Unterberg-Buchwald C; Schaefer IM; Kertesz A
    Am J Hematol; 2012 Apr; 87(4):426-7. PubMed ID: 21953722
    [No Abstract]   [Full Text] [Related]  

  • 6. R-CHOP: does one size fit all in diffuse large B cell lymphoma?
    Barnes JA; Abramson JS
    Acta Haematol; 2014; 131(3):153-5. PubMed ID: 24192325
    [No Abstract]   [Full Text] [Related]  

  • 7. Front-line management of diffuse large B cell lymphoma.
    Cabanillas F
    Curr Opin Oncol; 2010 Nov; 22(6):642-5. PubMed ID: 20811278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addictive response of primary cutaneous diffuse large B cell lymphoma leg type to low-dose ibrutinib.
    Pang A; Au-Yeung R; Leung RYY; Kwong YL
    Ann Hematol; 2019 Oct; 98(10):2433-2436. PubMed ID: 31446456
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic tumour volume and response to therapy in diffuse large B-cell lymphoma.
    Campiotti L; Suter MB; De Palma D; Proserpio I; Uccella S; Squizzato A
    Hematol Oncol; 2019 Aug; 37(3):308-309. PubMed ID: 30933368
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensified chemotherapy for diffuse large B-cell lymphomas.
    Vose JM
    Lancet; 2011 Nov; 378(9806):1828-9. PubMed ID: 22118432
    [No Abstract]   [Full Text] [Related]  

  • 11. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America.
    Beltran BE; Castillo JJ; Salas R; Quiñones P; Morales D; Cotrina E; Miranda RN; Sotomayor EM
    Leuk Lymphoma; 2011 Jan; 52(1):153-6. PubMed ID: 21219127
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
    Akhtar S; Maghfoor I
    N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
    [No Abstract]   [Full Text] [Related]  

  • 13. Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.
    Ruan J; Martin P; Furman RR; Lee SM; Cheung K; Vose JM; Lacasce A; Morrison J; Elstrom R; Ely S; Chadburn A; Cesarman E; Coleman M; Leonard JP
    J Clin Oncol; 2011 Feb; 29(6):690-7. PubMed ID: 21189393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ictus cerebellopontine as first manifestation of an intravascular diffuse large B cell lymphoma involving at the kidney].
    Sagüés M; Paredes V; Altés J; Fernández de Sevilla A
    Med Clin (Barc); 2015 Jan; 144(1):48-9. PubMed ID: 24698716
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FcγRIIA and FcγRIIIA polymorphisms do not influence survival and response to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy in patients with diffuse large B-cell lymphoma.
    Fabisiewicz A; Paszkiewicz-Kozik E; Osowiecki M; Walewski J; Siedlecki JA
    Leuk Lymphoma; 2011 Aug; 52(8):1604-6. PubMed ID: 21657954
    [No Abstract]   [Full Text] [Related]  

  • 17. What is your diagnosis? Cutaneous B-cell lymphoma.
    Carlson SW; Aneja S; Honda K; Cooper KD
    Cutis; 2014 Nov; 94(5):217, quiz 249-51. PubMed ID: 25474456
    [No Abstract]   [Full Text] [Related]  

  • 18. High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance).
    Witzig TE; LaPlant B; Habermann TM; McPhail E; Inwards DJ; Micallef IN; Colgan JP; Nowakowski GS; Ansell SM; Johnston PB
    Blood Cancer J; 2017 Jun; 7(6):e576. PubMed ID: 28649983
    [No Abstract]   [Full Text] [Related]  

  • 19. Worsening of psoriasis with rituximab therapy.
    Olivieri I; D'Angelo S; Leccese P; Vertone D; Olivieri A
    Clin Exp Rheumatol; 2010; 28(6):926. PubMed ID: 21205468
    [No Abstract]   [Full Text] [Related]  

  • 20. Large gastrosplenic fistula after effective treatment of abdominal diffuse large-B-cell lymphoma.
    Palmowski M; Zechmann C; Satzl S; Bartling S; Hallscheidt P
    Ann Hematol; 2008 Apr; 87(4):337-8. PubMed ID: 17929016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.